About Epigenica
Epigenica is a company based in Stockholm (Sweden) founded in 2020 by Simon Alsatian and Mohamad Takwa. Epigenica has raised $2.2 million across 2 funding rounds from investors including European Union, Almi and Leksell Social Ventures. Epigenica offers products and services including EpiFinder Platform and EpiFinder Genome Kit. Epigenica operates in a competitive market with competitors including Chroma Medicine, FOXO Technologies, Reaction Biology, Inherent Biosciences and Chronomics, among others.
- Headquarter Stockholm, Sweden
- Founders Simon Alsatian, Mohamad Takwa
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epigenica Ab
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.2 M (USD)
in 2 rounds
-
Latest Funding Round
$2.2 M (USD), Seed
Jun 30, 2025
-
Investors
European Union
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epigenica
Epigenica offers a comprehensive portfolio of products and services, including EpiFinder Platform and EpiFinder Genome Kit.
High-throughput technology for multiplexed epigenetic profiling and research.
Commercial kit for genome-wide epigenomic analysis in multiple samples.
People of Epigenica
Unlock access to complete
Unlock access to complete
Funding Insights of Epigenica
Epigenica has successfully raised a total of $2.2M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.2 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Epigenica
Epigenica has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Almi and Leksell Social Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding is provided for deep tech ventures in Nordics.
|
Locked | Locked | Locked | |
|
Navigare Ventures is focused on early-stage science-driven investments.
|
Locked | Locked | Locked | |
|
Impact investments are focused on by this private equity firm.
|
Locked | Locked | Locked |
Investor details for Epigenica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epigenica
Investment portfolio details for Epigenica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epigenica
Detailed financials for Epigenica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epigenica Comparisons
Peer comparison for Epigenica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epigenica
Epigenica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Chroma Medicine, FOXO Technologies, Reaction Biology, Inherent Biosciences and Chronomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Epigenetic editing platform is developed for genomic medicines.
|
|
| Locked | Locked | Locked |
Epigenetic biomarkers are discovered and developed via AI platforms.
|
|
| Locked | Locked | Locked |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| Locked | Locked | Locked |
Epigenetic diagnostics and therapeutics for complex diseases are developed.
|
|
| Locked | Locked | Locked |
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
|
|
| Locked | Locked | Locked |
Epigenetic kits, reagents, and assays are supplied for research applications.
|
Detailed competitors of Epigenica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epigenica
Complete news archive for Epigenica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epigenica
Epigenica was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Epigenica is headquartered in Stockholm, Sweden.
Mohamad Takwa is the current CEO of Epigenica. They have also founded this company.
Epigenica is a funded company, having raised a total of $2.2M across 2 funding rounds to date.
Provider of solutions for the analysis of genomic data. The platform is offering tools, EpiQure, for testing epigenetic drug efficacy and toxicity screening in real-life pilots, EpiFinder, for large-scale biomarker discovery for disease diagnosis and prognosis, and EpIVD, which helps in lowering the cost of epigenetic diagnostics.
Epigenica's top competitors include Chroma Medicine, FOXO Technologies and EpiCypher.
Epigenica offers EpiFinder Platform and EpiFinder Genome Kit.
Epigenica has 5 investors. Key investors include European Union, Almi, Leksell Social Ventures, Voima Ventures, and Navigare Ventures.